ProPhase Labs to Release Fourth Quarter/Year End Results on Tuesday, March 29th

DOYLESTOWN, PA -- (Marketwired) -- 03/25/16 -- ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the fourth quarter, ended December 31, 2015, will be released before the market opens on Tuesday, March 29, 2016. A conference call will be held later that morning on March 29th, at 11:00am EST. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and fourth quarter results. There will be a question and answer session following initial remarks.

The conference call will be webcast live at https://engage.vevent.com/rt/prophaselabsincao~032916 at 11:00 AM (EDT) on Tuesday, March 29, 2016.

Participants wishing to ask questions may access the live call by dialing (844) 301-0501 conference ID # 76794886. A replay of the conference call will be available for 90 days on the company website www.ProPhaseLabs.com.

About ProPhase Labs

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE® cold remedy brand as well as other cold and flu relief products. Cold-EEZE® cold remedy zinc gluconate lozenges are clinically proven to significantly reduce the duration of the common cold. Cold-EEZE® cold remedy customers include leading national chain, regional, specialty and local retail stores. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE® cold remedy lozenges and fulfill other contract manufacturing opportunities. For more information visit us at www.ProPhaseLabs.com.

   
    
      Press Only Contact
     Constantine Panagiotatos DKC Public Relations Tel: (212) 981-5124 [email protected] Investor ContactTed KarkusChairman and CEOProPhase Labs, Inc.(215) 345-0919 x 0

Source: ProPhase Labs

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• American International Group (AIG) PT Raised to $89 at Piper Sandler
• Intuitive Surgical (ISRG) PT Raised to $435 at Piper Sandler